Announcements
On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Extended deadline (from 1 July to 31 July) 2017 for call to submit papers on effectiveness and cost-effectiveness of screening and prevention of infectious diseases among newly arrived migrants in Europe. Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc


Skip Navigation LinksEurosurveillance Archives
Eurosurveillance:
2017        2016        2015        2014        2013        2012        2011        2010        2009        2008        2007        2006       
2005        2004        2003        2002        2001        2000        1999        1998        1997        1996        1995       

Eurosurveillance Editions 2014,  Volume 19:
Dec: 18 | 11 | 04 |
Nov: 27 | 20 | 13 | 06 |
Oct: 30 | 23 | 16 | 09 | 02 |
Sep: 25 | 18 | 11 | 04 |
Aug: 28 | 21 | 14 | 07 |
Jul: 31 | 24 | 17 | 10 | 03 |
Jun: 26 | 19 | 12 | 05 |
May: 29 | 22 | 15 | 08 | 01 |
Apr: 24 | 17 | 10 | 03 |
Mar: 27 | 20 | 13 | 06 |
Feb: 27 | 20 | 13 | 06 |
Jan: 30 | 23 | 16 | 09 |

Eurosurveillance Special Editions 2014,  Volume 19:
  Chikungunya and Zika virus - October 2014
  Polio - October 2014


In this issue:
Preliminary results from New Zealand suggest 54% effectiveness of influenza vaccine against hospitalisation for influenza and 67% against presentations to sentinel general practices


Eurosurveillance, Volume 19, Issue 42, 23 October 2014

Table of Contents

Rapid communications

Continued seasonal circulation of enterovirus D68 in the Netherlands, 2011–2014
Assessing the impact of travel restrictions on international spread of the 2014 West African Ebola epidemic
Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014
Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014
Surveillance and outbreak reports

Multiple human-to-human transmission from a severe case of psittacosis, Sweden, January–February 2013
Surveillance of invasive Neisseria meningitidis with a serogroup Y update, Sweden 2010 to 2012
Miscellaneous

Addendum for Euro Surveill. 2014;19(8)
Addendum for Euro Surveill. 2014;19(38)
Author’s correction for Euro Surveill. 2014;19(35)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.